# Litfulo

NDC: 63539-334
Generic name: ritlecitinib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230706

FDA application: NDA215830

## Active ingredients

- RITLECITINIB TOSYLATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-334"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-334
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1882f799-61b0-4813-965a-4910c4ae419c